The role of investors and leveraging capital in a post-Roe world

The U.S. spends more than any other industrialized nation on healthcare, yet has the highest maternal mortality, which will worsen with the recent decision to overturn Roe v. Wade. Additionally, less than 2% of all US venture capital funding is invested in women’s healthcare innovation. Asset owners and investors can support access to healthcare and mitigate the harm that Roe will have on women and birthing people. Join this session to learn about the broader landscape, shareholder activism, and strategies for leveraging investments to expand innovation in women’s healthcare.  Impact investor advocates for racial and gender equity must attend!